Oryzon Genomics

Therapeutic programs ORYZON is a clinical stage biopharmaceutical company that leverages epigenetics to discover and develop innovative personalized therapeutics for patients with cancers and CNS disorders. We are able to identify and validate biomarkers and therapeutic targets through our epigenetic platform and translate them into advanced and personalized therapies. Epigenetics is a regulatory system that controls gene expression without affecting the makeup of the genes themselves.